Tyrosine Phosphatase Epsilon Is a Positive Regulator of Osteoclast Function in Vitro and in Vivo

Molecular Biology of the Cell

Volumn 15, Issue 1, 2004, Pages 234-244

  Chiusaroli, Riccardo ^a   Knobler, Hilla ^b   Luxenburg, Chen ^c   Sanjay, Archana ^a   Granot Attas, Shira ^c   Tiran, Zohar ^c   Miyazaki, Tsuyoshi ^a   Harmelin, Alon ^c   Baron, Roland ^a   Elson, Ari ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAPLAN MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; FOCAL ADHESION KINASE 2; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN SUBUNIT; TELOPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BONE DEFECT; BONE MARROW; BONE MASS; CELL ASSAY; CELL CULTURE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; GENDER; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION;

ANIMALS; BONE AND BONES; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; COLLAGEN; ENZYME ACTIVATION; ESTROGENS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; OSTEOBLASTS; OSTEOCLASTS; PHOSPHORYLATION; PROGESTERONE; PROTEIN-TYROSINE-PHOSPHATASE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

ANIMALIA;

EID: 9144223721     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-04-0207     Document Type: Article

References (65)

1. Andersen, J.N., Elson, A., Lammers, R., Romer, J., Clausen, J.T., Moller, K.B., and Moller, N.P.H. (2001a). Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling. Biochem. J. 354, 581-590.
2. Andersen, J.N. et al. (2001b). Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21, 7117-7136.
3. Aoki, K. et al. (1999). The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice. Bone 25, 261-267.
4. Boyce, B.F., Yoneda, T., Lowe, C., Soriano, P., and Mundy, G.R. (1992). Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90, 1622-1627.
5. Chen, W.T. (1989). Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251, 167-185.
6. Chengalvala, M.V., Bapat, A.R., Hurlburt, W.W., Kostek, B., Gonder, D.S., Mastroeni, R.A., and Frail, D.E. (2001). Biochemical characterization of osteotesticular protein tyrosine phosphatase and its functional significance in rat primary osteoblasts. Biochemistry 40, 814-821.
7. Destaing, O., Saltel, F., Geminard, J.C., Jurdic, P., and Bard, F. (2003). Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol. Biol. Cell 14, 407-416.
8. Duong, L.T., Lakkakorpi, P.T., Nakamura, I., Machwate, M., Nagy, R.M., and Rodan, G.A. (1998). PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. J. Clin. Invest. 102, 881-892.
9. Elson, A. (1999). Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice. Oncogene 18, 7535-7342.
10. Elson, A., and Leder, P. (1995a). Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu. J. Biol. Chem. 270, 26116-26122.
11. Elson, A., and Leder, P. (1995b). Identification of a cytoplasmic, phorbol ester-inducible isoform of protein tyrosine phosphatase epsilon. Proc. Natl. Acad. Sci. USA 92, 12235-12239.
12. Endo, N., Rutledge, S.J., Opas, E.E., Vogel, R., Rodan, G.A., and Schmidt, A. (1996). Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates. J. Bone Miner. Res. 11, 535-543.
13. Evans, J.G., Correia, I., Krasavina, O., Watson, N., and Matsudaira, P. (2003). Macrophage podosomes assemble at the leading lamella by growth and fragmentation. J. Cell Biol. 161, 697-705.
14. Fisher, J.E., Rodan, G.A., and Reszka, A.A. (2000). In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Endocrinology 141, 4793-4796.
15. Fisher, J.E. et al. (1999). Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc. Natl. Acad. Sci. USA 96, 133-138.
16. Gil-Henn, H., and Elson, A. (2003). Tyrosine phosphatase epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. J. Biol. Chem. 278, 15579-15586.
17. Gil-Henn, H., Volohonsky, G., and Elson, A. (2001). Regulation of protein-tyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic. J. Biol. Chem. 276, 31772-31779.
18. Gil-Henn, H., Volohonsky, G., Toledano-Katchalski, H., Gandre, S., and Elson, A. (2000). Generation of novel cytoplasmic forms of protein tyrosine phosphatase epsilon by proteolytic processing and translational control. Oncogene 19, 4375-4384.
19. Horne, W.C., Neff, L., Chatterjee, D., Lomri, A., Levy, J.B., and Baron, R. (1992). Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J. Cell Biol. 119, 1003-1013.
20. Hunter, T. (1995). Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
21. Krueger, N.X., Streuli, M., and Saito, H. (1990). Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J. 9, 3241-3252.
22. Lakkakorpi, P.T., Bett, A.J., Lipfert, L., Rodan, G.A. Duong, le T. (2003). PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J. Biol. Chem. 278, 11502-11512.
23. Lakkakorpi, P.T., and Vaananen, H.K. (1991). Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J. Bone Miner. Res. 6, 817-826.
24. Li, L., and Dixon, J.E. (2000). Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin. Immunol. 12, 75-84.
25. Linder, S., and Aepfelbacher, M. (2003). Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 13, 376-385.
26. Lowe, C., Yoneda, T., Boyce, B.F., Chen, H., Mundy, G.R., and Soriano, P. (1993). Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. USA 90, 4485-4489.
27. Marchisio, P.C., Cirillo, D., Naldini, L., Primavera, M.V., Teti, A., and Zambordn-Zallone, A. (1984). Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J. Cell Biol. 99, 1696-1705.
28. Marchisio, P.C., Cirillo, D., Teti, A., Zambonin-Zallone, A., and Tarone, G. (1987). Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions. Exp. Cell Res. 169, 202-214.
29. Mauro, L.J., Olmsted, E.A., Davis, A.R., and Dixon, J.E. (1996). Parathyroid hormone regulates the expression of the receptor protein tyrosine phosphatase, OST-PTP, in rat osteoblast-like cells. Endocrinology 137, 925-933.
30. Mauro, L.J., Olmsted, E.A., Skrobacz, B.M., Mourey, R.J., Davis, A.R., and Dixon, J.E. (1994). Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J. Biol. Chem. 269, 30659-30667.
31. Missbach, M., Jeschke, M., Feyen, J., Muller, K., Glatt, M., Green, J., and Susa, M. (1999). A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone 24, 437-449.
32. Miyazaki, T., Neff, L., Tanaka, S., Horne, W.C., and Baron, R. (2003). Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 160, 709-718.
33. Moller, N.P., Moller, K.B., Lammers, R., Kharitonenkov, A., Hoppe, E., Wiberg, F.C., Sures, I., and Ullrich, A. (1995). Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases alpha and epsilon. J. Biol. Chem. 270, 23126-23131.
34. Murakami, H. et al. (1997). Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts. Bone 20, 399-404.
35. Nakamura, K., Mizuno, Y., and Kikuchi, K. (1996). Molecular cloning of a novel cytoplasmic protein tyrosine phosphatase PTP epsilon. Biochem. Biophys. Res. Commun. 218, 726-732.
36. NRC (National Research Council). (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
37. Nermut, M.V., Eason, P., Hirst, E.M.A., and Kellie, S. (1991). Cell/substratum adhesions in RSV-transformed rat fibroblasts. Exp. Cell Res. 193, 382-397.
38. Opas, E.E., Rutledge, S.J., Golub, E., Stern, A., Zimolo, Z., Rodan, G.A., and Schmidt, A. (1997). Alendronate inhibition of protein-tyrosine-phosphatase-meg1. Biochem. Pharmacol. 54, 721-727.
39. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M., Recker, R.R. (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610.
40. Peretz, A., Gil-Henn, H., Sobko, A., Shinder, V., Attali, B., and Elson, A. (2000). Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon. EMBO J. 19, 4036-4045.
41. Ponniah, S., Wang, D.Z., Lim, K.L., and Pallen, C.J. (1999). Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr. Biol. 9, 535-538.
42. Rogers, M.J., Gordon, S., Benford, H.L., Coxon, F.P., Luckman, S.P., Monkkonen, J., and Frith, J.C. (2000). Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88, 2961-2978.
43. Sanjay, A. et al. (2001). Cb1 associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152, 181-195.
44. Schmidt, A. et al, (1996). Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc. Natl. Acad. Sci. USA 93, 3068-3073.
45. Skorey, K., Ly, H.D., Kelly, J., Hammond, M., Ramachandran, C., Huang, Z., Gresser, M.J., and Wang, Q. (1997). How does alendronate inhibit protein-tyrosine phosphatases? J. Biol. Chem. 272, 22472-22480.
46. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702.
47. Stickel, S.K., and Wang, Y.L. (1987). Alpha-actinin-containing aggregates in transformed cells are highly dynamic structures. J. Cell Biol. 104, 1521-1526.
48. Su, J., Muranjan, M., and Sap, J. (1999). Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol. 9, 505-511.
49. Suhr, S.M., Pamula, S., Baylink, D.J., and Lau, K.H. (2001). Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption. J. Bone Miner. Res. 16, 1795-1803.
50. Sully, V., Pownall, S., Vincan, E., Bassal, S., Borowski, A.H., Hart, P.H., Rockman, S.P., and Phillips, W.A. (2001). Functional abnormalities in protein tyrosine phosphatase epsilon-deficient macrophages. Biochem. Biophys. Res. Commun. 286, 184-188.
51. Tanuma, N., Nakamura, K., and Kikuchi, K. (1999). Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. Eur. J. Biochem. 259, 46-54.
52. Tanuma, N., Nakamura, K., Shima, H., and Kikuchi, K. (2000). Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. J. Biol. Chem. 275, 28216-28221.
53. Tanuma, N., Shima, H., Nakamura, K., and Kikuchi, K. (2001). Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin-10-induced JAK-STAT signaling. Blood 98, 3030-3034.
54. Tanuma, N., Shima, H., Shimada, S., and Kikuchi, K. (2003). Reduced tumorigenicity of murine leukemia cells expressing protein-tyrosine phosphatase, PTP epsilon C. Oncogene 22, 1758-1762.
55. Tarone, G., Cirillo, D., Giancotti, F.G., Comoglio, P.M., and Marchisio, P.C. (1985). Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp. Cell Res. 159, 141-157.
56. Toledano-Katchalski, H., Kraut, J., Sines, T., Granot-Attas, S., Shohat, G., Gil-Henn, H., Yung, Y., and Elson, A. (2003). Protein tyrosine phosphatase Epsilon inhibits signaling by mitogen-activated protein kinases. Mol. Cancer Res. 1, 541-550.
57. Tonks, N.K., and Neel, B.G. (2001). Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13, 182-195.
58. Umeda, S., Beamer, W.G., Takagi, K., Naito, M., Hayashi, S., Yonemitsu, H., Yi, T., and Shultz, L.D. (1999). Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am. J. Pathol. 155, 223-233.
59. Violette, S. M. et al. (2001). Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption. Bone 28, 54-64.
60. Violette, S.M. et al. (2000). A Src SH2 selective binding compound inhibits osteoclast-mediated resorption. Chem. Biol. 7, 225-235.
61. Wabakken, T., Hauge, H., Finne, E.F., Wiedlocha, A., and Aasheim, H.-C. (2002). Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase. Scand. J. Immunol. 56, 195-203.
62. Wu, L.W., Baylink, D.J., and Lau, K.H. (1996). Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase. Biochem. J. 316, 515-523.
63. Zambonin-Zallone, A., Teti, A., Carano, A., and Marchisio, P.C. (1988). The distribution of podosomes in osteoclasts cultured on bone laminae: effect of retinol. J. Bone Miner. Res. 3, 517-523.
64. Zamir, E., Katz, B.Z., Aota, S., Yamada, K.M., Geiger, B., and Kam, Z. (1999). Molecular diversity of cell-matrix adhesions. J. Cell Sci. 112, 1655-1169.
65. Zheng, X.M., Wang, Y., and Pallen, C.J. (1992). Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature 359, 336-339.